retatrutide phase 2 nejm 2023 obesity trial jastreboff 💉 may be redefining treatment. New data from TRIUMPH-1 showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Retatrutide Results: 24% Weight Loss

Build better habits, achieve your ideal weight, and become a stronger, healthier you

It's on the left hand side of your left tibia and the right hand side of your right one

You can click on the snack icon, then click update to move the food to the correct location

If the data continues to show reduced substance use disorders, fewer ER visits, and lower hospital admissions, the total cost of care equation changes significantly

Personalized Care: Our program includes comprehensive consultations and health assessments by a licensed, board-certified physician assistant who will tailor your treatment plan to your needs

10.1186/s12964-022-00821-7